Tag: Alemtuzumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Alemtuzumab

Fisher Asset Management LLC Lifted Stake in Sanofi SA (SNY)

Added to Collection on: 2019-02-26 02:56:15

Tags for this article:

Economy of France
CAC 40
SNY
Sanofi
Life Sciences
Companies
SANOFI SA
Alemtuzumab
Price–earnings ratio

Click the tags to see associated articles and topics

View Article Details
Sanofi SA (NYSE:SNY) Stake Decreased by Advisors Asset Management Inc.

Added to Collection on: 2019-03-14 19:26:15

Tags for this article:

Dividend
Economy of France
CAC 40
Advisors Asset Management Inc.
SNY
Sanofi
Iduronidase
Life Sciences
Companies
SANOFI SA
Alemtuzumab

Click the tags to see associated articles and topics

View Article Details
Sanofi (EPA:SAN) Given a €95.00 Price Target at Sanford C. Bernstein

Added to Collection on: 2019-09-10 16:15:00

Tags for this article:

Finance
Economy
Financial analyst
Securities research
Sanofi
Iduronidase
Companies
Alemtuzumab

Click the tags to see associated articles and topics

View Article Details
4657 Shares in Sanofi SA (NYSE:SNY) Bought by Koshinski Asset Management Inc.

Added to Collection on: 2020-02-04 22:15:00

Tags for this article:

Sanofi
Companies
CAC 40
SNY
Alemtuzumab
SANOFI SA

Click the tags to see associated articles and topics

View Article Details
Sanofi – Consensus Indicates Potential 31.6% Upside

Added to Collection on: 2021-01-27 21:22:30

Tags for this article:

Drugs
Clinical medicine
Medicine
Sanofi
Insulin glargine/lixisenatide
Insulin glulisine
Insulin
Alglucosidase alfa
Iduronidase
Lixisenatide
Alemtuzumab
Thymoglobulin
SANOFI-AVENTIS

Click the tags to see associated articles and topics

View Article Details
'A Pinkalicious Phase': What We Heard This Week

Added to Collection on: 2021-03-07 21:00:00

Tags for this article:

Medical research
Cladribine
Organochlorides
Purines
Alemtuzumab
COVID-19 vaccine
Multiple sclerosis
Health sciences
Health

Click the tags to see associated articles and topics

View Article Details
Multiple Sclerosis Drugs Market Size 2021 | Is Projected to Reach USD 40.66 Billion by 2027 ...

Added to Collection on: 2021-04-29 11:07:00

Tags for this article:

Life Sciences
Medical specialties
Health sciences
Multiple sclerosis
Monoclonal antibodies
Autoimmune diseases
Breakthrough therapy
Management of multiple sclerosis
Biogen
Ocrelizumab
Alemtuzumab
Sanofi

Click the tags to see associated articles and topics

View Article Details
Resetting immune system with stem cells could treat common form of MS - Hackney Gazette

Added to Collection on: 2023-09-25 22:49:24

Tags for this article:

Multiple sclerosis
Autoimmune diseases
Stem cells
Neurological disorders
Monoclonal antibodies
Hematopoietic stem cell transplantation
Management of multiple sclerosis
Alemtuzumab
Cladribine
Stem-cell therapy
Ocrelizumab
Malignant multiple sclerosis

Click the tags to see associated articles and topics

View Article Details
Resetting immune system with stem cells could treat common form of MS – study

Added to Collection on: 2023-09-25 22:47:59

Tags for this article:

Multiple sclerosis
Stem cells
Autoimmune diseases
Biotechnology
Cell biology
Hematopoietic stem cell transplantation
Alemtuzumab
Management of multiple sclerosis
Cladribine
Stem-cell therapy
Ocrelizumab
Cell therapy

Click the tags to see associated articles and topics

View Article Details
Investigating the effect of alemtuzumab in allogeneic hematopoietic cell transplantation in ...

Added to Collection on: 2024-07-26 15:41:24

Tags for this article:

Transplantation medicine
Graft-versus-host disease
Hematopoietic stem cell transplantation
Alemtuzumab
CD52
Allotransplantation
T-cell depletion
Microtransplantation

Click the tags to see associated articles and topics

View Article Details